Transdermal drug delivery mediated by microneedle arrays: Innovations and barriers to success

Current Pharmaceutical Design

Volumn 22, Issue 9, 2016, Pages 1105-1117

  Caffarel Salvador, Ester ^a   Donnelly, Ryan F ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Drug delivery; Microneedles; Minimally invasive; Perceptions; Sterility; Transdermal

Indexed keywords

INFLUENZA VACCINE; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; DRUG;

BIOCOMPATIBILITY; DRUG COST; DRUG PENETRATION; DRUG RELEASE; ELECTROPORATION; GASTROINTESTINAL ABSORPTION; HUMAN; HYDROGEL; HYPODERMIC NEEDLE; INFLUENZA VACCINATION; INTERSTITIAL FLUID; MACROMOLECULE; MICRONEEDLE; MINIMALLY INVASIVE PROCEDURE; NOCICEPTION; OPTICAL COHERENCE TOMOGRAPHY; PAIN INTENSITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; QUALITY OF LIFE; REVIEW; SKIN CONDUCTANCE; SKIN PENETRATION; SKIN PERMEABILITY; SKIN WATER LOSS; SKINFOLD THICKNESS; TRANSDERMAL DRUG ADMINISTRATION; TRANSDERMAL PATCH; VISUAL ANALOG SCALE; ANIMAL; CUTANEOUS DRUG ADMINISTRATION; DRUG DELIVERY SYSTEM; MICROINJECTION; NEEDLE; PROCEDURES;

ADMINISTRATION, CUTANEOUS; ANIMALS; DRUG DELIVERY SYSTEMS; HUMANS; MICROINJECTIONS; NEEDLES; PHARMACEUTICAL PREPARATIONS;

EID: 84961707435     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612822666151216145645     Document Type: Review

References (128)

1. Davis SP, Landis BJ, Adams ZH, et al. Insertion of microneedles into skin: measurement and prediction of insertion force and needle fracture force. J Biomech 2004; 37: 1155-63.
2. Benson HAE. Skin structure, function, and permeation. In: Benson HAE, Watkinson AC. Eds. Transdermal and topical drug delivery: principles and practice. Hoboken, NJ, USA: John Wiley & Sons, Inc. 2011.
3. Lee JW, Gadiraju P, Park JH, et al. Microsecond thermal ablation of skin for transdermal drug delivery. J Control Release 2011; 154: 58-68.
4. Li S, Ed. Electroporation protocols: preclinical and clinical gene medicine. Totowa, NJ: Humana Press 2008.
5. Bariya SH, Gohel MC, Mehta TA, et al. Microneedles: an emerging transdermal drug delivery system. J Pharm Pharmacol 2012; 64: 11-29.
6. Migalska K, Morrow D, Garland MJ, et al. Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery. Pharm Res 2011; 28: 1919-30.
7. Donnelly RF, Majithiya R, Singh TR, et al. Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique. Pharm Res 2011; 28: 41-57.
8. McGrath JA, Eady RAJ, Pope FM. Anatomy and organization of human skin, in Rook's textbook of dermatology. Uk: Blackwell Publishing, Inc. 2008; pp. 45-128.
9. Wiechers JW. The barrier function of the skin in relation to percutaneous absorption of drugs. Pharm Week Bl Sci 1989; 11: 185-98.
10. Deli MA. Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. Biochim Biophys Acta 2009; 1788: 892-910
11. Andrews SN, Jeong E, Prausnitz MR. Transdermal delivery of molecules is limited by full epidermis, not just stratum corneum. Pharm Res 2013; 30: 1099-109.
12. PMPNews website: http://www.pmpnews.com/news/transdermaldelivery-market-predicted-reach-315-billion-2015-pharmalivespecial-report [Accessed April 2015].
13. Subramony JA. Needle free parenteral drug delivery: leveraging active transdermal technologies for pediatric use. Int J Pharm 2013; 455: 14-8.
14. Donnelly RF, Singh TR, Morrow DIJ, et al. Microneedle-mediated transdermal and intradermal drug delivery. Oxford: Wiley-Blackwell 2012.
15. Kersten G, Hirschberg H. Needle-free vaccine delivery. Expert Opin Drug Deliv 2007; 4: 459-74.
16. Sekkat N, Naik A, Kalia YN, et al. Reverse iontophoretic monitoring in premature neonates: feasibility and potential. J Contol Release 2002; 81: 83-9.
17. Tanner T, Marks R. Delivering drugs by the transdermal route: review and comment. Skin Res Technol 2008; 14: 249-60.
18. Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev 2004; 56: 603-18.
19. Gerstel MS, Place VA. Drug delivery device U.S. Patent No. 3,964,482 1976.
20. Kim YC, Park JH, Prausnitz MR. Microneedles for drug and vaccine delivery. Adv Drug Deliv Rev 2012; 64: 1547-68.
21. Bal S, Caussin J, Pavel S, Bouwstra J. In vivo assessment of safety of microneedle arrays in human skin. Eur J Pharm Sci 2008; 35: 193-202.
22. Haq M, Smith E, John D, et al. Clinical administration of microneedles: skin puncture, pain and sensation. Biomed Microdevices 2009; 11: 35-47.
23. Norman JJ, Arya JM, McClain MA, et al. Microneedle patches: usability and acceptability for self-vaccination against influenza. Vaccine 2014; 32: 1856-62.
24. Birchall JC. Microneedle array technology: the time is right but is the science ready? Expert Rev Med Devices 2006; 3: 1-4.
25. Martanto W, Davis S, Holiday N, et al. Transdermal delivery of insulin using microneedles in vivo. Pharm Res 2004; 21: 947-52.
26. Davis SP, Martanto W, Allen MG, et al. Hollow metal microneedles for insulin delivery to diabetic rats. IEEE Trans Bio Med Eng 2005; 52: 909-15.
27. Davidson A, Al-Qallaf B, Das DB. Transdermal drug delivery by coated microneedles: Geometry effects on effective skin thickness and drug permeability. Chem Eng Res Des 2008; 86: 1196-206.
28. Kommareddy S, Baudner BC, Bonificio A, et al. Influenza subunit vaccine coated microneedle patches elicit comparable immune responses to intramuscular injection in guinea pigs. Vaccine 2013; 31: 3435-41.
29. Lee J, Park J, Prausnitz M. Dissolving microneedles for transdermal drug delivery. Biomaterials 2008; 29: 2113-24.
30. Garland MJ, Caffarel-Salvador E, Migalska K, et al. Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery. J Control Release 2012; 159: 52-9.
31. Donnelly RF, McCrudden MT, Zaid Alkilani A, et al. Hydrogelforming microneedles prepared from "super swelling" polymers combined with lyophilised wafers for transdermal drug delivery. PLoS One 2014; 9: e111547.
32. Jin T. Phase-transition polymeric microneedles. Shanghai US Patent No: 20110195124A1, 2011.
33. Amin F, Ahmed S. Design, modeling and simulation of MEMSbased silicon Microneedles. J Phys: Conf Ser 2013; 439: 012049.
34. Chandrasekaran S, Brazzle JD, Frazier AB. Surface micromachined metallic microneedles. J Mems 2003; 12: 281-8.
35. Verbaan FJ, Bal SM, Van den DJB, et al. Improved piercing of microneedle arrays in dermatomed human skin by an impact insertion method. J Control Release 2008; 128: 80-8.
36. Perennes F, Marmiroli B, Matteucci M, et al. Sharp beveled tip hollow microneedle arrays fabricated by LIGA and 3D soft lithography with polyvinyl alcohol. J Micromech Microeng 2006; 16: 473-9.
37. Han M, Kim D, Seong H, et al. Improvement in antigen-delivery using fabrication of a grooves-embedded microneedle array. Sensor Actuat. B-Chem 2009; 137: 274-80.
38. Sammoura F, Kang JJ, Heo YM, et al. Polymeric microneedle fabrication using a microinjection molding technique. Microsyst Technol 2007; 13: 517-22.
39. Lippmann JM, Pisano AP. In-Plane, hollow microneedles via polymer investment molding. MEMS IEEE 19th Int Conf 2006; pp. 262-5.
40. Yamamoto T, Yamamoto Y. Electrical properties of the epidermal stratum corneum. Med Biol Eng 1976; 14: 151-8.
41. Park JH, Allen MG, Prausnitz MR. Biodegradable polymer microneedles: fabrication, mechanics and transdermal drug delivery. J Control Release 2005; 104: 51-66.
42. Kavanagh GM, Oh C, Shams K. Botox delivery by iontopheresis. Br J Dermatol 2005; 151: 1093-95.
43. Park JH, Yoon YK, Choi SO, et al. Tapered conical polymer microneedles fabricated using an integrated lens technique for transdermal drug delivery. IEEE Trans Bio-Med Eng 2007; 54: 903-13.
44. Bhatia G, Banga AK. Effect of modulated alternating and direct current iontophoresis on transdermal delivery of lidocaine hydrochloride. Biomed Res Int 2014; 15: 537941.
45. Siegel SJ, O’Neill C, Dubé LM, et al. A unique iontophoretic patch for optimal transdermal delivery of sumatriptan succinate. Pharm Res 2007; 24: 1919-26.
46. Mudry B, Guy R, Delgado-Charro M. Prediction of iontophoretic transport across the skin. J Control Release 2006; 111: 362-7.
47. McAllister DV, Wang PM, Davis SP, et al. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies. Proc Natl Acad Sci 2003; 100: 13755-60.
48. Yan K, Todo H, Sugibayashi K. Transdermal drug delivery by inskin electroporation using a microneedle array. Int J Pharm 2010; 397: 77-83.
49. Hikima T, Ohsumi S, Shirouzu K, et al. Mechanisms of synergistic skin penetration by sonophoresis and iontophoresis. Biol Pharm Bull 2009; 32: 905-9.
50. Katikaneni S, Badkar A, Nemab S, et al. Molecular charge mediated transport of a 13 kD protein across microporated skin. Int J Pharm 2009; 378: 93-100.
51. Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol 2008; 26: 1261-8.
52. Gill HS, Prausnitz MR. Coated microneedles for transdermal delivery. J Control Release 2007; 117: 227-37.
53. Muller DA, Corrie SR, Coffey J, et al. Surface modified microprojection arrays for the selective extraction of the dengue virus NS1 protein as a marker for disease. Anal Chem 2012; 84: 3262-8.
54. Kumar AV, Kulkarni PR, Raut RA. Microneedles: promising technique for transdermal drug delivery. Int J Pharm Bio Sci 2011; 2: 684-708.
55. Corrie S, Fernando GJP, Crichton ML, et al. Surface-modified microprojection arrays for intradermal biomarker capture, with low non-specific protein binding. Lab Chip 2010; 10: 2655-8.
56. Ashraf MW, Tayyaba S, Nisar A, et al. Design, fabrication and analysis of silicon hollow microneedles for transdermal drug delivery system for treatment of hemodynamic dysfunctions. Cardiovasc Eng 2010; 10: 91-108.
57. Donnelly R, Garland M, Morrow D, et al. Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution. J Control Release 2010; 147: 333-41.
58. Mukerjee E, Collins S, Isseroff R, et al. Microneedle array for transdermal biological fluid extraction and in situ analysis. Sens Actuat A Phys 2004; 114: 267-75.
59. Donnelly RF, Thakur RRS, Garland MJ, et al. Hydrogel-forming microneedle arrays for enhanced transdermal drug delivery. Adv Funct Mater 2012; 22: 4879-90.
60. Kim B, La Flamme K, Peppas NA. Dynamic swelling behavior of pH-sensitive anionic hydrogels uses for protein delivery. J Appl Polym Sci 2003; 89: 1606-13.
61. Am Ende MT, Hariharan D, Peppas NA. Factors influencing drug and protein transport and release from ionic hydrogels. React Polym 1995; 25: 127-37.
62. Emileh A, Vasheghani-Farahani E, Imani M. Swelling behavior, mechanical properties and network parameters of pH-and temperature sensitive hydrogels of poly((2-dimethyl amino) ethyl methacrylate-co-butyl methacrylate). Eur Polym J 2007; 43: 1986-95.
63. Mitragotri S, Blankschtein D, Langer R. Ultrasound-mediated transdermal protein delivery. Science 1995; 269: 850-3.
64. Thakur RRS, McCarron PA, Woolfson AD, et al. Investigation of swelling and network parameters of poly(ethylene glycol)-crosslinked poly(methyl vinyl ether-co-maleic acid) hydrogels. Eur Polym J 2009; 45: 1239-49.
65. Donnelly RF, Woolfson AD, McCarron PA, et al. Microneedles/delivery device and method. British Patent Application No 0718996.2. Filed September 28th 2007. International publication No WO2009040548 2007.
66. Demir YK, Akan Z, Kerimoglu O. Characterization of polymeric microneedle arrays for transdermal drug delivery. PLoS One 2013; 8: e77289.
67. Yang S, Feng Y, Zhang L, et al. A scalable fabrication process of polymer microneedles. Int J Nanomed 2012; 7: 1415-22.
68. Qiu Y, Qin G, Zhang S, et al. Novel lyophilized hydrogel patches for convenient and effective administration of microneedlemediated insulin delivery. Int J Pharm 2012; 437: 51-6.
69. Kim M, Jung B, Park JH. Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin. Biomaterials 2012; 33: 668-78.
70. Chu LY, Prausnitz MR. Separable arrowhead microneedles. J Control Release 2011; 149: 242-9.
71. Donnelly RF, Garland MJ, Alkilani AZ. Microneedle-iontophoresis combinations for enhanced transdermal drug delivery. Methods Mol Biol 2014; 1141: 121-32.
72. Kis EE, Winter G, Myschik J. Devices for intradermal vaccination. Vaccine 2012; 30: 523-38.
73. Van Damme P, Oosterhuis-Kafeja F, Van der Wielen M, et al. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults. Vaccine 2009; 27: 454-9.
74. Zhang Y, Brown K, Siebenaler K, et al. Development of lidocainecoated microneedle product for rapid, safe, and prolonged local analgesic action. Pharm Res 2012; 29: 170-7.
75. Banga AK. Transdermal and Intradermal Delivery of Therapeutic Agents: Application of Physical Technologies. USA: CRC Press Taylor & Francis Group LLC 2011.
76. Daddona PE, Matriano JA, Mandema J, et al. Parathyroid hormone (1-34)-coated microneedle patch system: clinical pharmacokinetics and pharmacodynamics for treatment of osteoporosis. Pharm Res 2011; 28: 159-65.
77. Clinical trials website (A service of the U.S. National Institutes of Health): https://clinicaltrials.gov/show/NCT00453934 [Accessed May 2015].
78. Corium website: www.coriumgroup.com [Accessed April 2015].
79. Perumal O, Murthy SN, Kalia YN. Turning theory into practice: the development of modern transdermal drug delivery systems and future trends. Skin Pharmacol Physiol 2013; 26: 331-42.
80. Centers for Medicare & Medicaid Services. Seasonal influenza vaccines pricing; 2015 http://www.cms.gov/Medicare/Medicare-Fee-for-Service-Part-B-Drugs/McrPartBDrugAvgSalesPrice/VaccinesPricing.html [Accessed June 2015].
81. Prosser LA, O’Brien MA, Molinari NA, et al. Non-traditional settings for influenza vaccination of adults: costs and costeffectiveness. Pharmacoeconomics 2008; 26: 163-78.
82. Sander B, Kwong JC, Bauch CT, et al. Economicappraisal of Ontario’s Universal Influenza Immunization Program: a costutilityanalysis. PLoS Med 2010; 7: e1000256.
83. Lohmann Therapy Systems website: www.ltslohmann.de/home.html [Accessed April 2015].
84. Lee CY, You YS, Lee SH, et al. Tower microneedle minimizes vitreal reflux in intravitreal injection. Biomed Microdevices 2013; 15: 841-8.
85. Donnelly R, Mooney K, Caffarel-Salvador E, et al. Microneedlemediated minimally invasive patient monitoring. Ther Drug Monit 2014; 36: 10-7.
86. Tayyaba S, Ashraf MW, Afzulpurkar N. Design and simulation of double lumen polymeric microneedles for blood transport. Proc Int Conf Mech Electrical Technol (ICMET) 2010; pp. 615-8.
87. Wang PM, Cornwell M, Prausnitz MR. Minimally invasive extraction of dermal interstitial fluid for glucose monitoring using microneedles. Diabetes Technol Ther 2005; 7: 131-41.
88. Wang PM, Cornwell M, Hill J, et al. Precise microinjection into skin using hollow microneedles. J Invest Dermatol 2006; 126: 1080-7.
89. Li G, Badkar A, Nema S, et al. In vitro transdermal delivery of therapeutic antibodies using maltose microneedles. Int J Pharm 2009; 368: 109-15.
90. Crichton ML, Ansaldo A, Chen X, et al. The effect of strain rate on the precision of penetration of short densely-packed microprojection array patches coated with vaccine. Biomaterials 2010; 31: 4562-72.
91. Larraneta E, Moore J, Vicente-Pérez EM, et al. A proposed model membrane and test method for microneedle insertion studies. Int J Pharm 2014; 472: 65-73
92. Kalluri H, Kolli CS, Banga AK. Characterization of microchannels created by metal microneedles: Formation and closure. AAPS J 2011; 13: 473-81.
93. Donnelly RF, Mooney K, McCrudden MTC, et al. Hydrogelforming microneedles increase in volume during swelling in skin, but skin barrier function recovery is unaffected. J Pharm Sci 2014; 103: 1478-86.
94. Hitzenberger CK. Optical measurement of the axial eye length by laser Doppler interferometry. Invest Ophthalmol Vis Sci 1991; 32: 616-24.
95. Jones RS, Darling CL, Featherstone JD, et al. Remineralization of in vitro dental caries assessed with polarization-sensitive optical coherence tomography. J Biomed Opt 2006; 11: 014016.
96. Isenberg G, Sivak MV Jr, Chak A, et al. Accuracy of endoscopic optical coherence tomography in the detection of dysplasia in Barrett's esophagus: a prospective, double-blinded study. Gastrointest Endosc 2005; 62: 825-31.
97. Hsiung PL, Pantanowitz L, Aguirre AD, et al. Ultrahigh-resolution and 3-dimensional optical coherence tomography ex vivo imaging of the large and small intestines. Gastrointest Endosc 2005; 62: 561-74.
98. Bal S, Kruithof AC, Liebl H, et al. In vivo visualisation of microneedle conduits in human skin using laser scanning microscopy. Laser Phys Lett 2010; 3: 242-6.
99. Enfield J, O'Connell ML, Lawlor K, et al. In vivo dynamic characterization of microneedle skin penetration using optical coherence tomography. J Biomed Opt 2010; 15: 046001.
100. Coulman S, Birchall JC, Alex A. In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography. Pharm Res 2011; 28: 66-81.
101. Zaric M, Lyubomska O, Touzelet O, et al. Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-d,l-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses. ACS Nano 2013; 7: 2042-55.
102. Kim CS, Ahn YC, Wilder-Smith P, et al. Efficient and facile delivery of gold nanoparticles in vivo using dissolvable microneedles for contrast-enhanced optical coherence tomography. Biomed Opt Express 2010; 1: 106-13.
103. Coulman SA, Birchall JC, Alex A, et al. In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography. Pharm Res 2011; 28: 66-81.
104. Brogden NK, Banks SL, Crofford LJ, et al. Diclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans. Pharm Res 2013; 30: 1947-55.
105. Ghosh P, Brogden NK, Stinchcomb AL. Fluvastatin as a micropore lifetime enhancer for sustained delivery across microneedle-treated skin. J Pharm Sci 2014: 103(2): 652-60.
106. Kaushik S, Hord A, Denson D, et al. Lack of pain associated with microfabricated microneedles. Anesth Analg 2001; 92: 502-4.
107. Gill HS, Denson DD, Burris B, et al. Effect of microneedle design on pain in human subjects. Clin J Pain 2008; 24: 585-94.
108. Wermeling DP, Banks SL, Hudson DA, et al. Microneedles permit transdermal delivery of a skin-impermeant medication to humans. Proc Natl Acad Sci USA 2008; 105: 2058-63.
109. Donnelly RF, Singh TR, Alkilani AZ, et al. Hydrogel-forming microneedle arrays exhibit antimicrobial properties: Potential for enhanced patient safety. Int J Pharm 2013; 451: 76-91.
110. Gupta J, Felner EI, Prausnitz MR. Minimally invasive insulin delivery in subjects with type 1 diabetes using hollow microneedles. Diabetes Technol Ther 2009; 11: 329-37.
111. Gupta J, Park SS, Bondy B, et al. Infusion pressure and pain during microneedle injection into skin of human subject. Biomaterials 2011; 32: 6823-31.
112. Sivamani RK, Stoeber B, Wu GC, et al. Clinical microneedle injection of methyl nicotinate: stratum corneum penetration. Skin Res Technol 2005; 11: 152-6.
113. Birchall JC, Clemo R, Anstey A, et al. Microneedles in clinical practice -an exploratory study into the opinions of healthcare professionals and the public. Pharm Res 2011; 28: 95-106.
114. Mooney K, McElnay JC, Donnelly RF. Parents' perceptions of microneedle-mediated monitoring as an alternative to blood sampling in the monitoring of their infants. Int J Pharm Pract 2015; doi: 10.1111/ijpp.12195
115. Mooney K, McElnay JC, Donnelly RF. Children's views on microneedle use as an alternative to blood sampling for patient monitoring. Int J Pharm Pract 2014; 22: 335-44.
116. Caffarel-Salvador E, Mahmood TMT, McElnay JC, et al. Potential of hydrogel-forming and dissolving microneedles for use in paediatric populations. Int J Pharm 2015; 489: 158-69.
117. Zosano Pharma website: http: //www.zosanopharma.com/index php/20091106127/Research/Research-General/ZP-PTH.html [Accessed April 2015].
118. Bhat-Schelbert K, Lin CJ, Matambanadzo A, et al. Barriers to and facilitators of child influenza vaccine -perspectives from parents, teens, marketing and healthcare professionals. Vaccine 2012; 30: 2448-52.
119. Donnelly RF, Thakur RRS, Tunney MM., et al. Microneedle arrays allow lower microbial penetration than hypodermic needles in vitro. Pharm Res 2009; 26: 2513-22.
120. Wei-Ze L, Mei-Ronga H, Jian-Pinga Z. Super-short solid silicon microneedles for transdermal drug delivery applications. Int J Pharm 2010; 389: 122-9.
121. McCrudden MT, Alkilani AZ, Courtenay AJ, et al. Considerations in the sterile manufacture of polymeric microneedle arrays. Drug Deliv Transl Res 2015; 5: 3-14.
122. Nanopass website: http://www.nanopass.com/contente.asp?cid=19#; [Accessed May 2015].
123. Dermaroller website: http://www.dermarollersystem.com/index.html [Accessed May 2015].
124. Valeritas website: https://www.valeritas.com/technologies/h_patch [Accessed May 2015].
125. 3M webiste: http://solutions.3m.com/3MContentRetrievalAPI/BlobServlet?lmd=1410811883000&locale=en_WW&assetType=MMM_Image&assetId=1361805169080&blobAttribute=ThumbnailImage [Accessed May 2015].
126. Fluzone website: http://www.fluzone.com/fluzone-intradermalvaccine.cfm [Accessed May 2015].
127. Zosano Pharma website: http://www.zosanopharma.com/index.php/20091103117/Research/Research-General/Technology-Platform.html [Accessed May 2015].
128. Rouged website: http: //rougedblog.com/sugar-scrub/ [AccessedMay 2015].